Calibrate, founded in 2020, is transforming the treatment of obesity through its clinician-guided and value-based outcomes model. With a mission embodied in its slogan, "We're changing the way the world treats weight," this United States-based startup combines medication with transformative behavior change to enhance metabolic health.
Calibrate leverages a cost-effective approach designed to deliver long-term weight loss results, thereby reducing overall care expenses for both employers and payers. This innovative method has garnered recognition from distinguished entities, including the World Economic Forum’s Technology Pioneers, Fast Company’s World Changing Ideas, and TIME’s Best Inventions.
Backed by health-focused investors such as Madryn Asset Management and Redesign Health, Calibrate recently secured further backing in a Private Equity Round on 01 November 2023, affirming its potential in revolutionizing healthcare outcomes.